42 U.S. Code § 1395w–153 - Condition for coverage of drugs under this part
prev | next
(a)
In general
In order for coverage to be available under this part for covered part D drugs (as defined in section
1395w–102
(e) of this title) of a manufacturer, the manufacturer must—
(1)
participate in the Medicare coverage gap discount program under section
1395w–114a of this title;
(b)
Effective date
Subsection (a) shall apply to covered part D drugs dispensed under this part on or after January 1, 2011.
(c)
Authorizing coverage for drugs not covered under agreements
Subsection (a) shall not apply to the dispensing of a covered part D drug if—
(1)
the Secretary has made a determination that the availability of the drug is essential to the health of beneficiaries under this part; or
(2)
the Secretary determines that in the period beginning on January 1, 2011, and
[1]
December 31, 2011, there were extenuating circumstances.
(d)
Definition of manufacturer
In this section, the term “manufacturer” has the meaning given such term in section
1395w–114a
(g)(5) of this title.
[1] So in original. Probably should be followed by “ending on”.
Source
(Aug. 14, 1935, ch. 531, title XVIII, § 1860D–43, as added Pub. L. 111–148, title III, § 3301(a),Mar. 23, 2010, 124 Stat. 461; amended Pub. L. 111–152, title I, § 1101(b)(1),Mar. 30, 2010, 124 Stat. 1037.)
Amendments
2010—Subsec. (b). Pub. L. 111–152, § 1101(b)(1)(A), substituted “January 1, 2011” for “July 1, 2010”.
Subsec. (c)(2). Pub. L. 111–152, § 1101(b)(1)(B), substituted “January 1, 2011, and December 31, 2011,” for “July 1, 2010, and ending on December 31, 2010,”.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.